Genprex Inc
Change company Symbol lookup
Select an option...
GNPX Genprex Inc
OKTA Okta Inc
APD Air Products and Chemicals Inc
DUK Duke Energy Corp
NKE Nike Inc
AAPL Apple Inc
VXRT Vaxart Inc
VIGI Vanguard International Dividend Appreciation Index Fund ETF Shares
VIG Vanguard Dividend Appreciation Index Fund ETF Shares
VIAC ViacomCBS Inc
Go

Health Care : Biotechnology |
Company profile

Genprex, Inc. is a clinical-stage gene therapy company. The Company is focused on developing cancer-based upon its novel technology platform, including its initial product candidate, Oncoprex, immunogene therapy, or Oncoprex. Oncoprex consists of a tumor suppressor gene inserted into a patient’s cells that has immunomodulatory effects and is thereby considered an immunogene therapy. The gene is one of a series of genes whose therapeutic use is covered by a license from The University of Texas MD Anderson Cancer Center (MD Anderson). It is also developing a pre-clinical gene therapy that is covered by a license from the University of Pittsburgh of the Commonwealth System of Higher Education that has the potential to cure type 1 and type 2 diabetes. It is developing its product candidate to be administered with targeted therapies and with immunotherapies for non-small cell lung cancer (NSCLC).

Premarket

Last Trade
Delayed
$3.61
0.025 (0.70%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$3.58
Day's Change
0.00 (0.00%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
1,530

10-day average volume:
783,078
1,530

Display:

Providers:

UpdateCancel
6 providers
August 05, 2020
LD Micro - Announces Preliminary List of Presenters for the LD-500

LOS ANGELES, CA / ACCESSWIRE / August 5, 2020 / LD Micro today announced the initial list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online.(Accesswire)

July 31, 2020
Genprex to Present at Proactive's One2One Virtual Investor Forum on August 4, 2020

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, announced today that the Company will present at the Proactive...(BusinessWire)

July 30, 2020
Genprex CEO Participates in a Second-Round Live Interview on the "Big Biz Show"

Genprex, Inc. ("Genprex" or the "Company") (Nasdaq: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, today announced that its Chairman and Chief Executive Officer...(BusinessWire)

July 21, 2020
National Institutes of Health (NIH) Awards Research Grant of $2.59 Million to University of Pittsburgh for Diabetes Gene Therapy Technology Licensed by Genprex

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, today announced that Dr. George K. Gittes, MD of the University...(BusinessWire)

June 29, 2020
Genprex Added to Russell 3000(R) Index

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, today announced that it was added to the Russell 3000(R) Index...(BusinessWire)

June 25, 2020
Genprex Receives USAN Approval of Non-Proprietary Name for Lead Drug Candidate

--Lead drug candidate for NSCLC now referred to as quaratusugene ozeplasmid or GPX-001 --Company rebrands use of Oncoprex(TM) name for Nanoparticle Delivery Platform Genprex, Inc. ("Genprex" or the "Company") (Nasdaq: GNPX), a clinical-stage gene...(BusinessWire)

June 24, 2020
Genprex CEO to Interview Live on "The Big Biz Show"

Genprex, Inc. ("Genprex" or the "Company") (Nasdaq: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, today announced that its Chairman and Chief Executive Officer...(BusinessWire)

June 16, 2020
Genprex Expands Manufacturing Program with Aldevron to Advance Oncoprex(TM) Clinical Development

--Manufacturing program supports upcoming clinical trials, including Oncoprex in combination with Tagrisso(R), which received FDA Fast Track Designation Genprex, Inc. ("Genprex" or the "Company") (Nasdaq: GNPX), a clinical-stage gene therapy company...(BusinessWire)

June 09, 2020
Genprex Scheduled to Join Russell 3000(R) Index

Genprex, Inc. ("Genprex" or the "Company") (Nasdaq: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, today announced that it is scheduled to join the U.S...(BusinessWire)

June 08, 2020
Genprex to Present at the MoneyShow June Virtual Event

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, announced that the Company will present at the MoneyShow June...(BusinessWire)

May 28, 2020
Genprex Announces Receipt of $2.5 Million in Cash from Recent Warrant Exercises

Genprex, Inc. ("Genprex" or the "Company") (Nasdaq: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, announced today that warrants to purchase approximately 5.4...(BusinessWire)

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.